Evidence map›Paper›PMID 32581080›Full record

ArticlemSphere2020

Michael W Panas, John C Boothroyd

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Heliyon · 2023
    Review
  6. ThemSphere · 2023
    Article
  7. Article
  8. Article
  9. Single Cell Transcriptomes ofFrontiers in cellular and infection microbiology · 2022
    Article
  10. Article
  11. Secreted Effectors Modulating Immune Responses toLife (Basel, Switzerland) · 2021
    Review
  12. Review
  13. Review
  14. Computational and structural biotechnology journal · 2021
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael W PanasDepartment of Microbiology and Immunology, Stanford School of Medicine, Stanford, California, USA.ORCID 0000-0002-2973-736X
John C BoothroydDepartment of Microbiology and Immunology, Stanford School of Medicine, Stanford, California, USA jboothr@stanford.edu.
Stanford Medicine · US

Funding

Toxoplasma Rhoptry FunctionR01AI021423 · NIAID · STANFORD UNIVERSITY · PI BOOTHROYD, JOHN C · 1985 to 2018
$7.8M
Identifying The Machinery That Translocates Toxoplasma Effectors Into The Host CellR01AI129529 · NIAID · STANFORD UNIVERSITY · PI BOOTHROYD, JOHN C · 2018 to 2021
$2.2M
NIAID NIH HHS R01 AI021423NIAID NIH HHS R01 AI129529
6 · The paper itself

Abstract

Manipulation of the host cell is a crucial part of life for many intracellular organisms. We have recently come to appreciate the extent to which the intracellular pathogen

Indexed as

Cells, CulturedFibroblastsHost-Pathogen InteractionsHumansNeosporaPlasmidsProto-Oncogene MasProto-Oncogene Proteins c-mycProtozoan ProteinsToxoplasmaTranscriptional ActivationUp-RegulationVirulence FactorsMAS1 protein, humanMYC protein, humanProto-Oncogene MasProto-Oncogene Proteins c-mycProtozoan ProteinsVirulence Factorsc-Myceffector proteinGRA16host-microbial interaction

Identifiers

PMID32581080
PMCPMC7316491
OpenAlexW3037339940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.